Table 3.
Changes in marker gene expression in the placodes after injection of various constructs.
| Injection | Six1-MO* | Eya1-MO* | Six1-EnR | Eya1-mmMO | Six1-GR§ | Eya1-GR§ | |
|---|---|---|---|---|---|---|---|
| Phenotype | % | % | % | % | % | % | |
| (n) | (n) | (n) | (n) | (n) | (n) | ||
| Atoh1 | Reduced | 77** | 90‡ | 94 | 10 | 26 | 42 |
| (26) | (20) | (18) | (21) | (19) | (12) | ||
| Increased | 0 | 0 | 0 | 0 | 35 | 42 | |
| (26) | (20) | (18) | (21) | (17) | (12) | ||
| Gfi1a | Reduced | 82† | 67† | 69 | 31 | 57 | 36 |
| (27) | (17) | (16) | (26) | (14) | (14) | ||
| Increased | 0 | 0 | 0 | 0 | 7 | 43 | |
| (27) | (17) | (16) | (26) | (14) | (14) | ||
| Hes8 | Reduced | 74‡ | 83‡ | 70 | 17 | 60 | 57 |
| (35) | (35) | (46) | (24) | (40) | (56) | ||
| Increased | 0 | 0 | 24 | 0 | 15 | 29 | |
| (35) | (35) | (46) | (24) | (40) | (56) | ||
| Hes9 | Reduced | 73‡ | 76‡ | 84 | 11 | 75 | 29 |
| (45) | (33) | (38) | (27) | (12) | (29) | ||
| Increased | 0 | 0 | 8 | 0 | 0 | 0 | |
| (45) | (33) | (38) | (27) | (12) | (29) | ||
| Isl2 | Reduced | 66† | 100‡ | nd | 27 | 50 | 24 |
| (38) | (17) | nd | (22) | (18) | (17) | ||
| Increased | 6 | 0 | nd | 0 | 31 | 41 | |
| (38) | (17) | nd | (22) | (16) | (17) | ||
| Ngn1 | Reduced | 65‡ | 49† | 84 | 17 | 17 | 36 |
| (51) | (43) | (31) | (24) | (30) | (59) | ||
| Increased | 0 | 16 | 6 | 4 | 23 | 41 | |
| (51) | (43) | (31) | (24) | (30) | (59) | ||
| Pou4f1.2 | Reduced | 67‡ | 63† | 71 | 16 | 47 | 81 |
| (48) | (30) | (35) | (19) | (15) | (37) | ||
| Increased | 0 | 0 | 0 | 0 | 13 | 0 | |
| (48) | (30) | (35) | (19) | (15) | (37) | ||
| Sox2 | Reduced | 74‡ | 78‡ | 87 | 6 | 90 | 48 |
| (19) | (18) | (30) | (16) | (21) | (33) | ||
| Increased | 0 | 0 | 23# | 0 | 0 | 12 | |
| (19) | (18) | (30) | (16) | (21) | (33) | ||
| Sox3 | Reduced | 68‡ | 54† | 39 | 9 | 49 | 40 |
| (25) | (26) | (31) | (22) | (25) | (23) | ||
| Increased | 0 | 0 | 71# | 0 | 16 | 17 | |
| (25) | (26) | (31) | (22) | (25) | (23) | ||
| Tlx1 | Reduced | 84† | 91‡ | 100 | 33 | 40 | 7 |
| (31) | (32) | (13) | (15) | (10) | (15) | ||
| Increased | 6 | 0 | 0 | 0 | 40 | 73 | |
| (31) | (32) | (13) | (15) | (10) | (15) |
* Significant differences (Fisher’s exact test);.
† p<0.05,.
‡ p<0.001) to Eya1-mmMO injections are indicated.
§ Dexamethasone treatment from stages 16–18 on.
# Expression ectopic in epidermis.
n: Number of embryos analysed at both neural plate (stage 14–16) and tail bud (stage 21–26) stage.
nd: Not determined.